Hyperimmune Globulins Intravenous (IV) or Subcutaneous (SC) bulk supplier for pharma manufacturers

Hyperimmune Globulins Intravenous (Iv) Or Subcutaneous (Sc) 100 mg/mL or 50 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) or Subcutaneous (SC) Solution

Available Strengths: 100 mg/mL or 50 mg/mL

Reference Brands: Tetanus IG (TIG), Varicella Zoster IG, Cytogam,RhoGAM,Hepatitis B Immune Globulin (HBIG)(US)

Hyperimmune globulins IV provide passive immunity by supplying concentrated, pathogen-specific antibodies. They neutralize viruses or toxins, prevent infections, and support immune defense in exposed or immunocompromised individuals. Benefits include rapid protection, reduced disease severity, and enhanced immune response during post-exposure prophylaxis or treatment of infectious diseases.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Hyperimmune globulins (IV), such as Cytogam or HBIG, are approved in the US by the FDA and in the EU via EMA for passive immunization against specific diseases like CMV, rabies, and hepatitis B. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed submissions for safety and efficacy, while the EMA ensures compliance with regional quality standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance is essential for timely approval and safe worldwide use, supporting effective disease prevention.

Hyperimmune Globulins Intravenous (Iv) Or Subcutaneous (Sc) — third party manufacturing & bulk supply

Hyperimmune Globulins Intravenous (Iv) Or Subcutaneous (Sc) 100 mg/mL or 50 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Hyperimmune Globulins Intravenous (Iv) Or Subcutaneous (Sc) is supplied as Intravenous (IV) or Subcutaneous (SC) Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Hyperimmune Globulins Intravenous (Iv) Or Subcutaneous (Sc) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Hyperimmune Globulins Intravenous (Iv) O... →

Back to Listing

Frequently Asked Questions

Hyperimmune Globulins Intravenous (IV) or Subcutaneous (SC) is listed as Intravenous (IV) or Subcutaneous (SC) Solution in 100 mg/mL or 50 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Hyperimmune Globulins Intravenous (IV) or Subcutaneous (SC) is referenced against Tetanus IG (TIG), Varicella Zoster IG, Cytogam,RhoGAM,Hepatitis B Immune Globulin (HBIG)(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.